142 related articles for article (PubMed ID: 3713923)
1. A novel nontoxic alkyl-phospholipid with selective antitumor activity, plasmanyl-(N-acyl)-ethanolamine (PNAE), isolated from degenerating chick embryonal tissues and from an anticancer biopreparation cACPL.
Kára J; Borovicka M; Liebl V; Smolíková J; Ubik K
Neoplasma; 1986; 33(2):187-205. PubMed ID: 3713923
[TBL] [Abstract][Full Text] [Related]
2. New tumoricidal semisynthetic ether phospholipid, plasmanyl-(N-acyl)ethanolamine (PNAE(s)) and enhancement of its tumoricidal activity by calcium ions.
Kára J; Konovalova AL; Krasnova MA; Liebl V; Bejsovcová L
Neoplasma; 1993; 40(4):213-7. PubMed ID: 8272147
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and metabolism of a new antitumor semisynthetic ether phospholipid, 14C-labeled plasmanyl-(N-acyl)ethanolamine, in mice bearing sarcoma Mc11.
Kára J; Zimakova NI; Serebryakova EA; Dĕdková V; Zolotaryov AE
J Cancer Res Clin Oncol; 1994; 120(11):662-7. PubMed ID: 7962042
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antiproliferative effect of cis-diammine-dichloroplatinum (II) and a new anticancer agent, plasmanyl-(N-acyl)-ethanolamine, an inhibitor of protein kinase C.
Mikhaevich IS; Vlasenkova NK; Gerasimova GK
Biomed Sci; 1991; 2(6):659-64. PubMed ID: 1841636
[TBL] [Abstract][Full Text] [Related]
5. The effect of biopreparation cACPL on the proliferative activity of haemopoietic and tumour cells.
Jurásková V
Folia Biol (Praha); 1988; 34(3):192-201. PubMed ID: 3203819
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein kinase C by semisynthetic phospholipid plasmanyl-(N-acyl)-ethanolamine, a nontoxic antitumor preparation.
Mikhaevich IS; Gerasimova GK; Kára J
Biochem Int; 1991 Jan; 23(2):215-20. PubMed ID: 1859429
[TBL] [Abstract][Full Text] [Related]
7. Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids.
Modolell M; Andreesen R; Pahlke W; Brugger U; Munder PG
Cancer Res; 1979 Nov; 39(11):4681-6. PubMed ID: 498095
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 1-O-alkyl-2-O-methyl-glycerophospholipids with potential antitumor activity.
Alunni-Bistocchi G; Orvietani PL; Ricci A; Binaglia L; Orlando M; Orlando P
Farmaco; 1990 May; 45(5):499-509. PubMed ID: 2222722
[TBL] [Abstract][Full Text] [Related]
9. Cytostatic effects of various alkyl phospholipid analogues on different cells in vitro.
Langen P; Maurer HR; Brachwitz H; Eckert K; Veit A; Vollgraf C
Anticancer Res; 1992; 12(6B):2109-12. PubMed ID: 1295455
[TBL] [Abstract][Full Text] [Related]
10. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
Klutchko SR; Hamby JM; Boschelli DH; Wu Z; Kraker AJ; Amar AM; Hartl BG; Shen C; Klohs WD; Steinkampf RW; Driscoll DL; Nelson JM; Elliott WL; Roberts BJ; Stoner CL; Vincent PW; Dykes DJ; Panek RL; Lu GH; Major TC; Dahring TK; Hallak H; Bradford LA; Showalter HD; Doherty AM
J Med Chem; 1998 Aug; 41(17):3276-92. PubMed ID: 9703473
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.
Hoffman DR; Hoffman LH; Snyder F
Cancer Res; 1986 Nov; 46(11):5803-9. PubMed ID: 3756924
[TBL] [Abstract][Full Text] [Related]
12. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
Houlihan WJ; Lee ML; Munder PG; Winslow CM; Cheon SH; D'Aries FJ; DeLillo AK; Jaeggi CS; Mason RB; Parrino VA
J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.
Sztanke K; Tuzimski T; Rzymowska J; Pasternak K; Kandefer-Szerszeń M
Eur J Med Chem; 2008 Feb; 43(2):404-19. PubMed ID: 17531354
[TBL] [Abstract][Full Text] [Related]
14. Glycerophospho-(N-acyl)-ethanolamine lipids in degenerating BHK cells.
Somerharju P; Renkonen O
Biochim Biophys Acta; 1979 Apr; 573(1):83-9. PubMed ID: 454642
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of a new compound from Prunus mume fruit that inhibits cancer cells.
Jeong JT; Moon JH; Park KH; Shin CS
J Agric Food Chem; 2006 Mar; 54(6):2123-8. PubMed ID: 16536585
[TBL] [Abstract][Full Text] [Related]
16. High-resolution separation and quantification of neutral lipid and phospholipid species in mammalian cells and sera by multi-one-dimensional thin-layer chromatography.
White T; Bursten S; Federighi D; Lewis RA; Nudelman E
Anal Biochem; 1998 Apr; 258(1):109-17. PubMed ID: 9527856
[TBL] [Abstract][Full Text] [Related]
17. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
18. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of palmitic acid found as a selective cytotoxic substance in a marine red alga.
Harada H; Yamashita U; Kurihara H; Fukushi E; Kawabata J; Kamei Y
Anticancer Res; 2002; 22(5):2587-90. PubMed ID: 12529968
[TBL] [Abstract][Full Text] [Related]
20. Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
Magistrelli A; Villa P; Benfenati E; Modest EJ; Salmona M; Tacconi MT
Drug Metab Dispos; 1995 Jan; 23(1):113-8. PubMed ID: 7720513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
